Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian L Strom

Showing results (11-20 of 250) with videos related to

Pageof 25
Sort By:
Pharmacoepidemiology and Drug Safety|June 19, 2003
Journal's policy regarding conflict of interestRonald Mann, Brian L Strom
JAMA|September 28, 2002
Pharmacist care and clinical outcomes for patients with reactive airways diseaseBrian L Strom, Sean Hennessy
The New England Journal of Medicine|April 17, 2007
PDUFA reauthorization--drug safety's golden moment of opportunity?Sean Hennessy, Brian L Strom
Journal of Chemical Ecology|November 13, 2004
Statistical problems encountered in trapping studies of scolytids and associated insectsJohn D Reeve, Brian L Strom
Pharmacoepidemiology and Drug Safety|August 9, 2007
In clarificationBrian L Strom, James D Lewis
Annals of Internal Medicine|April 12, 2016
What Stands in the Way of Making Hepatitis B and C Rare Diseases in the United States?Gillian J Buckley, Brian L Strom
LDI Issue Brief|September 13, 2006
Reacting to antibiotic allergiesAndrea J Apter, Brian L Strom
Pharmacoepidemiology and Drug Safety|April 17, 2007
The role of academia and the research community in assisting the Food and Drug Administration to ensure U.S. drug safetyVincent Lo Re, Brian L Strom
Clinical Trials (London, England)|October 23, 2009
On the importance of heterogeneity in meta-analysisStephen M Keefe, Brian L Strom
Annals of Internal Medicine|April 7, 2017
A National Strategy for the Elimination of Viral Hepatitis Emphasizes Prevention, Screening, and Universal Treatment of Hepatitis CGillian J Buckley, Brian L Strom
Pageof 25

Showing results (11-20 of 250) with videos related to

Sort By:
Pageof 25
Pharmacoepidemiology and Drug Safety|June 19, 2003
Journal's policy regarding conflict of interestRonald Mann, Brian L Strom
JAMA|September 28, 2002
Pharmacist care and clinical outcomes for patients with reactive airways diseaseBrian L Strom, Sean Hennessy
The New England Journal of Medicine|April 17, 2007
PDUFA reauthorization--drug safety's golden moment of opportunity?Sean Hennessy, Brian L Strom
Journal of Chemical Ecology|November 13, 2004
Statistical problems encountered in trapping studies of scolytids and associated insectsJohn D Reeve, Brian L Strom
Pharmacoepidemiology and Drug Safety|August 9, 2007
In clarificationBrian L Strom, James D Lewis
Annals of Internal Medicine|April 12, 2016
What Stands in the Way of Making Hepatitis B and C Rare Diseases in the United States?Gillian J Buckley, Brian L Strom
LDI Issue Brief|September 13, 2006
Reacting to antibiotic allergiesAndrea J Apter, Brian L Strom
Pharmacoepidemiology and Drug Safety|April 17, 2007
The role of academia and the research community in assisting the Food and Drug Administration to ensure U.S. drug safetyVincent Lo Re, Brian L Strom
Clinical Trials (London, England)|October 23, 2009
On the importance of heterogeneity in meta-analysisStephen M Keefe, Brian L Strom
Annals of Internal Medicine|April 7, 2017
A National Strategy for the Elimination of Viral Hepatitis Emphasizes Prevention, Screening, and Universal Treatment of Hepatitis CGillian J Buckley, Brian L Strom
Pageof 25